AGY Insider Trading

Insider Ownership Percentage: 93.21%
Insider Buying (Last 12 Months): £2,479,350.56
Insider Selling (Last 12 Months): GBX 0

Allergy Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allergy Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allergy Therapeutics Share Price & Price History

Current Price: GBX 3.40
Price Change: +0.30 (1.20%)
As of 05/21/2024 03:00 PM ET

This chart shows the closing price history over time for AGY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Allergy Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/9/2023Zheqing ShenInsiderBuy247,935,056GBX 1£2,479,350.56
11/10/2021Peter JensenInsiderBuy30,000GBX 36£10,800
See Full Table

SEC Filings (Institutional Ownership Changes) for Allergy Therapeutics (LON:AGY)

0.12% of Allergy Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Allergy Therapeutics logo
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Acarovac Plus, Pollinex, Synbiotics, and VLP Peanut. The company develops allergy vaccines for pollen, house dust mites, and animal fur, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Read More on Allergy Therapeutics

Today's Range

Now: GBX 3.40
Low: 3.30
High: 3.50

50 Day Range

MA: GBX 2.90
Low: 2.50
High: 3.40

52 Week Range

Now: GBX 3.40
Low: 0.80
High: 3.90

Volume

425,204 shs

Average Volume

905,637 shs

Market Capitalization

£162.18 million

P/E Ratio

N/A

Dividend Yield

8.33%

Beta

1.34

Who are the company insiders with the largest holdings of Allergy Therapeutics?

Allergy Therapeutics' top insider investors include:
  1. Zheqing Shen (Insider)
Learn More about top insider investors at Allergy Therapeutics.